Sei sulla pagina 1di 1

Polycarbophil 5 41

Table II: Pharmacopeial specifications for calcium polycarbophil. and their combinations in diabetic rabbits. Drug Dev Ind Pharm
1999; 25(6): 745–752.
Test USP 28 15 Ghelardi E, Tavanti A, Lupetti A, et al. Control of Candida
albicans murine vaginitis by topical administration of polycarbo-
Identification þ phil–econazole complex. Antimicrob Agents Chemother 1998;
Loss on drying 410% 42(9): 2434–2436.
Absorbing power 535 g/g 16 Oh YK, Park JS, Yoon H, Kim CK. Enhanced mucosal and
Organic volatile impurities þ systemic immune responses to a vaginal vaccine coadministered
with RANTES-expressing plasmid DNA using in situ-gelling
Calcium content (on dried basis) 18–22%
mucoadhesive delivery system. Vaccine 2003; 21(17–18): 1980–
1988.
17 Hubert P, Evrard B, Maillard C, et al. Delivery of granulocyte-
water absorbency of polycarbophil. The swollen polycarbo- macrophage colony-stimulating factor in bioadhesive hydrogel
stimulates migration of dendritic cells in models of human
phil gel then acts as a bulk laxative as it moves through the
papillomavirus-associated (pre)neoplastic epithelial lesions. Anti-
gastrointestinal tract. microb Agents Chemother 2004; 48(11): 4342–4348.
18 Kockisch S, Rees GD, Young SA, et al. Polymeric microspheres for
18 Comments drug delivery to the oral cavity: an in vitro evaluation of
mucoadhesive potential. J Pharm Sci 2003; 92(8): 1614–1623.
— 19 Kockisch S, Rees GD, Young SA, et al. In situ evaluation of drug-
loaded microspheres on a mucosal surface under dynamic test
conditions. Int J Pharm 2004; 276(1–2): 51–58.
20 Leitner VM, Guggi D, Krauland AH, Bernkop-Schnurch A. Nasal
19 Specific References delivery of human growth hormone: in vitro and in vivo evaluation
of a thiomer/glutathione microparticulate delivery system. J
1 Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive Control Release 2004; 100(1): 87–95.
delivery systems. I. Evaluation of mucoadhesive polymers for 21 Umamaheswari RB, Jain S, Tripathi PK, et al. Floating-bioadhesive
buccal tablet formulation. Drug Dev Ind Pharm 2004; 30(9): 985– microspheres containing acetohydroxamic acid for clearance of
993. Helicobacter pylori. Drug Deliv 2002; 9(4): 223–231.
2 Jain AC, Aungst BJ, Adeyeye MC. Development and in vivo 22 Langoth N, Kalbe J, Bernkop-Schnurch A. Development of buccal
evaluation of buccal tablets prepared using danazol–sulfobuty- drug delivery systems based on a thiolated polymer. Int J Pharm
lether 7 beta-cyclodextrin (SBE 7) complexes. J Pharm Sci 2002; 2003; 252(1–2): 141–148.
91(7): 1659–1668. 23 Bernkop-Schnurch A, Thaler SC. Polycarbophil–cysteine conju-
3 Akbari J, Nokhodchi A, Farid D, et al. Development and gates as platforms for oral polypeptide delivery systems. J Pharm
evaluation of buccoadhesive propranolol hydrochloride tablet Sci 2000; 89(7): 901–909.
formulations: effect of fillers. Farmaco 2004; 59(2): 155–161. 24 Kast CE, Guggi D, Langoth N, Bernkop-Schnurch A. Development
4 El-Samaligy MS, Yahia SA, Basalious EB. Formulation and and in vivo evaluation of an oral delivery system for low molecular
evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm weight heparin based on thiolated polycarbophil. Pharm Res
2004; 286(1–2): 27–39. 2003; 20(6): 931–936.
5 Jay S, Fountain W, Cui Z, Mumper RJ. Transmucosal delivery of 25 Marschutz MK, Caliceti P, Bernkop-Schnurch A. Design and in
testosterone in rabbits using novel bi-layer mucoadhesive wax-film vivo evaluation of an oral delivery system for insulin. Pharm Res
composite disks. J Pharm Sci 2002; 91(9): 2016–2025. 2000; 17(12): 1468–1474.
6 Das NG, Das SK. Development of mucoadhesive dosage forms of 26 Marschutz MK, Puttipipatkhachorn S, Bernkop-Schnurch A.
buprenorphine for sublingual drug delivery. Drug Deliv 2004; Design and in vitro evaluation of a mucoadhesive oral delivery
11(2): 89–95. system for a model polypeptide antigen. Pharmazie 2001; 56(9):
7 Jones DS, Irwin CR, Woolfson AD, et al. Physicochemical 724–729.
characterization and preliminary in vivo efficacy of bioadhesive, 27 Hornof MD, Bernkop-Schnurch A. In vitro evaluation of the
semisolid formulations containing flurbiprofen for the treatment of permeation enhancing effect of polycarbophil–cysteine conjugates
gingivitis. J Pharm Sci 1999; 88(6): 592–598. on the cornea of rabbits. J Pharm Sci 2002; 91(12): 2588–2592.
8 Jones DS, Woolfson AD, Brown AF. Viscoelastic properties of 28 Valenta C, Walzer A, Clausen AE, Bernkop-Schnurch A. Thiolated
bioadhesive, chlorhexidine-containing semi-solids for topical polymers: development and evaluation of transdermal delivery
application to the oropharynx. Pharm Res 1998; 15(7): 1131– systems for progesterone. Pharm Res 2001; 18(2): 211–216.
1136. 29 Junginger HE, Verhoef JC. Macromolecules as safe penetration
9 Jones DS, Woolfson AD, Djokic J, Coulter WA. Development and enhancers for hydrophilic drugs—a fiction? Pharm Sci Tech Today
mechanical characterization of bioadhesive semi-solid, polymeric 1998; 1: 370–375.
systems containing tetracycline for the treatment of periodontal 30 The Registry of Toxic Effects of Chemical Substances. Atlanta:
diseases. Pharm Res 1996; 13(11): 1734–1738. National Institute for Occupational Safety and Health, 2004.
10 Jones DS, Woolfson AD, Brown AF, et al. Design, characterisation
and preliminary clinical evaluation of a novel mucoadhesive
topical formulation containing tetracycline for the treatment of 20 General References
periodontal disease. J Control Release 2000; 67(2–3): 357–368.
11 Nagarsenker MS, Londhe VY, Nadkarni GD. Preparation and Noveon Inc. Polycarbophil. http://www.pharma.noveon.com/
evaluation of liposomal formulations of tropicamide for ocular literature/msds/msdaa1.pdf (accessed 18 May 2005).
delivery. Int J Pharm 1999; 190(1): 63–71.
12 Park JS, Oh YK, Yoon H, et al. In situ gelling and mucoadhesive
polymer vehicles for controlled intranasal delivery of plasmid 21 Authors
DNA. J Biomed Mater Res 2002; 59(1): 144–151. KK Singh.
13 Yun M, Choi H, Jung J, Kim C. Development of a thermo-
reversible insulin liquid suppository with bioavailability enhance-
ment. Int J Pharm 1999; 189(2): 137–145. 22 Date of Revision
14 Hosny EA. Relative hypoglycemia of rectal insulin suppositories
containing deoxycholic acid, sodium taurocholate, polycarbophil, 25 August 2005.

Potrebbero piacerti anche